multicenter study

Type: Keyphrase
Name: multicenter study
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Positive early results of extended-range IOL reported

LONDON — Early positive experience with the Tecnis Symfony IOL, which received CE mark in Europe earlier this year, was related in a press briefing hosted by Abbott Medical Optics here.“Patients demand high-quality vision for a longer time, and they also ... [Published Orthopedics Today - 1 hour ago]
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

Making Treatment Decisions When There Is an Abundance of Options

Despite the benefit of having more choices than ever before to treat patients with multiple sclerosis (MS), the abundance of options has led to more complexity, according to speakers at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.In ... [Published American Journal of Managed Care - Sep 14 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

ECG tip positioning of central venous access devices in pediatric...

“The Italian Group for Venous Access Devices (GAVeCeLT) has carried out a multicenter study investigating the safety and accuracy of intracavitary electrocardiography (IC-ECG) in pediatric patients.” Rossetti et al (2014).Reference:Rossetti, F., Pittiruti, ... [Published IVTEAM - Sep 13 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

DiagnoCure announces results for third quarter of 2014 [Global Data Point]

Operating expenses decreased by $127,318 or 16%, to $657,529 for the third quarter of 2014 from $784,847 for the same period of 2013. At the end of the quarter, cash and short-term investments stood at $2,541,852.Based in part upon recent recommendations ... [Published Pharmacy Choice - Sep 12 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Endosonography for mediastinal nodal staging of clinical N1 non-small cell lung cancer: a prospective multicenter study

Background:   Patients with clinical N1 (cN1) lung cancer based on imaging are at risk for malignant mediastinal nodal involvement (N2-disease). Endosonography with a needle technique is suggested over surgical staging as a best first test for preoperative ... [Published CHEST - Sep 11 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 1 reports

Galena Biopharma Says Doses First Patient In GALE-401 Phase 2 Clinical Trial

Galena Biopharma, Inc. (GALE: Quote) Tuesday said the first patient has been dosed in its GALE-401 or Phase 2 clinical trial. The Phase 2 trial is an open-label, single-arm, multicenter study of GALE-401 in 20 patients with MPN-related thrombocytosis. ... [Published RTTNews.com - Sep 09 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris) - Abstract

OBJECTIVE: To evaluate an outcome of endoscopic correction of vesicoureteral reflux (VUR) using Vantris (Promedon, Cordoba, Argentina) in terms of its effectiveness and morbidity in a multicenter study.EndourologySurgical VideosRight Laparoscopic Radical ... [Published UroToday - Sep 09 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

First-Line Combination of Ambrisentan and Tadalafil Reduces Risk of Clinical Failure Compared to Monotherapy in Pulmonary Arterial Hypertension Outcomes Study

Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from the AMBITION study (a randomized, double-blind, multicenter study of first-line combination therapy with AMB r I sentan and T adalafil in patients…Click to Continue » ... [Published Fort Mills Times - Sep 08 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Multicenter Study of Trimethoprim/Sulfamethoxazole-Related Hepatotoxicity: Incidence and Associated Factors among HIV-Infected Patients Treated for Pneumocystis jirovecii Pneumonia

by Jen-Jia Yang, Chung-Hao Huang, Chun-Eng Liu, Hung-Jen Tang, Chia-Jui Yang, Yi-Chien Lee, Kuan-Yeh Lee, Mao-Song Tsai, Shu-Wen Lin, Yen-Hsu Chen, Po-Liang Lu, Chien-Ching HungThe incidence of hepatotoxicity related to trimethoprim/sulfamethoxazole (TMP/SMX) ... [Published Plosone.org - Sep 03 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Histological and Clinical Findings in Patients with Post-Transplantation and Classical Encapsulating Peritoneal Sclerosis: A European Multicenter Study

by Joerg Latus, Sayed M. Habib, Daniel Kitterer, Mario R. Korte, Christoph Ulmer, Peter Fritz, Simon Davies, Mark Lambie, M. Dominik Alscher, Michiel G. H. Betjes, Stephan Segerer, Niko Braun, on behalf of the European EPS study groupBackgroundEncapsulating ... [Published Plosone.org - Aug 29 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Positive Phase III Results Reported for BAX 855 in Treatment of Hemophilia A

Prophylaxis more effective than on-demand therapyPositive results have been reported from a phase III pivotal trial of BAX 855 (Baxter), an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on Advate ... [Published PT Community - Aug 22 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Pitt Analysis Questions Use of Acute Hemodialysis Treatment

PITTSBURGH – A common approach to treating kidney failure by removing waste products from the blood did not improve survival chances for people who suddenly developed the condition, in an analysis led by experts at the University of Pittsburgh School ... [Published Health Canal - Aug 20 2014]

Quotes

"The results from DECIDE further support the potential of ZINBRYTA and we look forward to submitting the data for this investigational therapy to regulatory agencies" said Michael Severino, M D , executive vice president, Research and Development and chief scientific officer, AbbVie
...Alan Tuchman, Senior Vice President, Medical and Clinical Affairs & Chief Medical Officer of Oncolytics. "These findings support previous evidence of REOLYSIN® being active in cancer cells with an activated RAS pathway and warrants confirmation of KRAS status as a potential predictive biomarker in future studies."
"The study also indicates that the procedure is safe for STEMI patients, and larger randomized trials with longer-term follow-up are warranted."
...Bode, a clinical associate professor in the department of medicine at Emory University and a diabetes specialist with Atlanta Diabetes Associates. "One of the biggest barriers to optimal self-management is the ability to calculate bolus doses. My hope is that the device will become the standard of care for patients on multiple daily insulin injection therapy due to the simplicity of the built-in bolus calculator."

More Content

All (135) | News (111) | Reports (1) | Blogs (21) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Positive early results of extended-range IOL re... [Published Orthopedics Today - 1 hour ago]
Biogen Idec and AbbVie Issues Phase 3 Decide St... [Published Individual.com - 12 hours ago]
Abiomed Inc. Announces Clinical Trial Results F... [Published BioMedReports - 17 hours ago]
Results of OCT STEMI trial reported at TCT 2014 [Published Bio-Medicine - 21 hours ago]
Results of OCT STEMI trial reported at TCT 2014 [Published Medical Xpress - 22 hours ago]
Roche launches blood-glucose meter with built-i... [Published Drug Store News - Sep 16 2014]
CSL Behring Announces Last Patient Treated In P... [Published BioSpace - Sep 16 2014]
CSL Behring Announces Last Patient Treated in P... [Published Business Wire Health News - Sep 16 2014]
Prostate cancer studies highlighted at ASTRO 2014 [Published Aunt Minnie - Sep 16 2014]
An Overview of Chemotherapy-Related Cognitive D... [Published Cancernetwork.com - Sep 16 2014]
Chemobrain: Is It Time to Initiate Guidelines f... [Published Cancernetwork.com - Sep 16 2014]
Guidelines for the Management of Neovascular AMD [Published General Medicine eJournal - Sep 16 2014]
DIAGNOCURE : Posts Third Quarter Results [Published 4 Traders - Sep 16 2014]
Anti-RhD Prophylaxis in RhD Negative Women With... [Published American Journal of Public Health - Sep 16 2014]
Comprehensive Prognosis Assessment by CMR Imagi... [Published Journal of the American College of Cardiology - Sep 15 2014]
Beaumont First in Michigan to Test Gene-Directe... [Published Diagnostic & Invasive Cardiology - Sep 15 2014]
Predicting heart transplant rejection with a bl... [Published My Sun Coast - Sep 15 2014]
High-dose radiation plus long-term ADT extended... [Published Orthopedics Today - Sep 15 2014]
Developing the first treatment for Acute Kidney... [Published Drug Discovery World - Sep 15 2014]
Lentis LaserLens could improve predictability, ... [Published Orthopedics Today - Sep 15 2014]
Two Drugs Better Than 1 for Pulmonary Hypertension [Published American Journal of Public Health - Sep 15 2014]
Adding Tomosynthesis to Digital Mammography Dec... [Published The ASCO Post - Sep 15 2014]
Making Treatment Decisions When There Is an Abu... [Published American Journal of Managed Care - Sep 14 2014]
ECG tip positioning of central venous access de... [Published IVTEAM - Sep 13 2014]
DiagnoCure announces results for third quarter ... [Published Pharmacy Choice - Sep 12 2014]
5 Reasons Why a Colonoscopy Is Better Than CT C... [Published Huffington Post - Sep 12 2014]
Novartis LCZ696: 'New Wonder Drug' OR 'Old Para... [Published Seeking Alpha - Sep 12 2014]
Endosonography for mediastinal nodal staging of... [Published CHEST - Sep 11 2014]
Medication Errors in Simulated Pediatric Resusc... [Published General Medicine eJournal - Sep 11 2014]
MEI Pharma : Completes Enrollment In Randomized... [Published 4 Traders - Sep 10 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
CSL Behring Announces Last Patient Treated in P... [Published Business Wire Health News - Sep 16 2014]
FLORENCE, Italy--(BUSINESS WIRE)--CSL Behring announced today that the last patient has been treated as part of the REPLACE (Randomized Evaluation of fibrinogen versus PLACEbo in complex cardiovascular surgery) Phase III clinical trial. REPLACE is the ...
First-Line Combination of Ambrisentan and Tadal... [Published Business Wire Health News - Sep 08 2014]
MUNICH--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from the AMBITION study (a randomized, double-blind, multicenter study of first-line combination therapy with AMBrIsentan and Tadalafil in patients with pulmonary arterial ...
Stem Cell Transplantation [Published Multiple Sclerosis Research - Aug 17 2014]
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D. Autologous hematopoietic stem cell transplantation ...
A balanced look at gluten sensitivity [Published Science-Based Medicine - Aug 16 2014]
Even though it doesn’t appear on any calendar, May 2014 will go down in history as “gluten sensitivity month.” After RealClearScience picked up on a 2013 paper that brought into question the existence of non-celiac gluten sensitivity (NCGS), news sites ...
Effects of switching to fingolimod [Published Multiple Sclerosis Research - Aug 06 2014]
Fox E et al. Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisDOI: 10.1016/j.msard.2014.06.005 Background ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Umecrine Mood reports preliminary data from exp... [Published GlobeNewswire: Acquisitions News - Jun 12 2014]
Saint Luke's awarded $3.4 million grant from Bo... [Published PR Newswire - Jan 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.